Dr. Rezal, a graduate of the Royal College of Surgeons in Ireland, completed his Basic Surgical Training in Limerick and was the first Malaysian awarded the Irish Scholarship for Research Fellowship at the University of Milwaukee, presenting his Neuroblastoma research in New Orleans in 2003. He holds an MRCS (Ire), a Diploma in Laparoscopic Surgery (Strasbourg), a Master of Surgery (University Malaya), and advanced training in Colorectal and Peritoneal Malignancy, specializing in Cytoreductive Surgery, HIPEC, and PIPAC. He is a member of the European Society of Surgical Oncology, Academy of Medicine Malaysia, Malaysian Society of Colorectal Surgeons, and ISSPP.

Main Congress Day 2 - 15 February 2025

Time Session
09:00
10:30
  • Palliative CRS with or without HIPEC
    Aras Emre Canda Speaker
  • Prophylactic HIPEC in Colorectal Cancer - Are We Overtreating?
  • Peritoneal Recurrence following CRS-HIPEC for Colorectal Peritoneal Metastasis
    Marc Paul Lopez Speaker
  • Setting-up CRS HIPEC Services in Malaysia
    Norfarizan Azmi Speaker
  • Q&A
Sipadan 1

Main Congress Day 3 - 16 February 2025

Time Session
10:30
12:00
ORAL PRESENTATION FREE PAPER
Sipadan 1

Presentation Slot

Time Session
10:30
12:00
  • The CREAFORMO-004 study: A phase II study of HR070803 plus 5-fluoruracil/leucovorin and bevacizumab as second-line treatment in patients with metastatic colorectal cancer
    AB-0099
    Jianling Zou Presenter
  • Triplet chemoradiotherapy with paclitaxel for squamous-cell anal cancer: a phase III trial
    AB-0016
    Sergey Gordeyev Presenter
  • Purse string Ileostomy Closure with NegatIve Pressure Wound Therapy: a Prospective Cohort Study in Patients Undergoing Stoma Closure Compared to a Retrospective Cohort Study
    AB-00130
    Carolyn Chew Presenter
  • Unpacking Empty Pelvis Syndrome: Risk Factors and Reconstruction Outcomes After Pelvic Exenteration
    AB-0073
    James Lockhart Presenter
  • Value of pre-operative endoscopy and magnetic resonance imaging in predicting pathological complete response in patients with rectal cancer following neoadjuvant therapy
    AB-0087
    Trevor Yeung Presenter
Sipadan 1